I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Toshiki Masuishi
123
results:
Search for persons
X
Format
Online (123)
Mediatypes
Articles (Online) (68)
OpenAccess-fulltext (55)
Sorted by: Relevance
Sorted by: Year
?
1
Survival impact of sequential chemotherapy following pembro..:
Iwaki, Sho
;
Kadowaki, Shigenori
;
Honda, Kazunori
...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 764-770 , 2024
Link:
https://doi.org/10.1007/..
?
2
Trifluridine/tipiracil with and without ramucirumab for adv..:
Narita, Yukiya
;
Ogata, Takatsugu
;
Ishizuka, Yasunobu
...
Scientific Reports. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
3
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trif..:
Matsumoto, Toshihiko
;
Yamamoto, Yoshiyuki
;
Kotaka, Masahito
...
Targeted Oncology. 19 (2024) 2 - p. 181-190 , 2024
Link:
https://doi.org/10.1007/..
?
4
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuxi..:
Kotani, Daisuke
;
Takashima, Atsuo
;
Kato, Takeshi
...
Clinical Colorectal Cancer. 23 (2024) 2 - p. 174-182.e6 , 2024
Link:
https://doi.org/10.1016/..
?
5
Sotorasib with panitumumab in chemotherapy-refractory KRASG..:
Kuboki, Yasutoshi
;
Fakih, Marwan
;
Strickler, John
...
Nature Medicine. 30 (2024) 1 - p. 265-270 , 2024
Link:
https://doi.org/10.1038/..
?
6
Risk factors affecting delay of initiating adjuvant chemoth..:
Maeda, Shingo
;
Ouchi, Akira
;
Komori, Koji
...
International Journal of Clinical Oncology. , 2024
Link:
https://doi.org/10.1007/..
?
7
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFO..:
Bando, Hideaki
;
Kotani, Daisuke
;
Satake, Hironaga
...
Med. , 2024
Link:
https://doi.org/10.1016/..
?
8
Chronological improvement of survival in patients with adva..:
Ogata, Takatsugu
;
Narita, Yukiya
;
Oze, Isao
...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024
Link:
https://doi.org/10.1177/..
?
9
Clinical outcomes of patients diagnosed with cancer of unkn..:
Ando, Masashi
;
Honda, Kazunori
;
Hosoda, Waki
...
International Journal of Clinical Oncology. 28 (2023) 5 - p. 644-653 , 2023
Link:
https://doi.org/10.1007/..
?
10
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiraci..:
Taniguchi, Hiroya
;
Yamazaki, Kentaro
;
Masuishi, Toshiki
...
The Oncologist. 28 (2023) 11 - p. e1108-e1113 , 2023
Link:
https://doi.org/10.1093/..
?
11
Randomised phase II trial of trifluridine/tipiracil (FTD/TP..:
Takahashi, Naoki
;
Hara, Hiroki
;
Nagashima, Kengo
...
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
12
Final results of DESTINY-CRC01 investigating trastuzumab de..:
Yoshino, Takayuki
;
Di Bartolomeo, Maria
;
Raghav, Kanwal
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
13
Fruquintinib versus placebo in patients with refractory met..:
Dasari, Arvind
;
Lonardi, Sara
;
Garcia-Carbonero, Rocio
...
The Lancet. 402 (2023) 10395 - p. 41-53 , 2023
Link:
https://doi.org/10.1016/..
?
14
Differential Efficacy of Targeted Monoclonal Antibodies in ..:
Kodama, Hiroyuki
;
Masuishi, Toshiki
;
Wakabayashi, Munehiro
...
Clinical Colorectal Cancer. 22 (2023) 3 - p. 298-306 , 2023
Link:
https://doi.org/10.1016/..
?
15
Nivolumab versus irinotecan as third- or later-line treatme..:
Kumanishi, Ryosuke
;
Kadowaki, Shigenori
;
Mitani, Seiichiro
...
International Journal of Clinical Oncology. 28 (2023) 6 - p. 756-763 , 2023
Link:
https://doi.org/10.1007/..
1-15